...
首页> 外文期刊>American Journal of Physiology >Endogenous cholecystokinin reduces food intake and increases Fos-like immunoreactivity in the dorsal vagal complex but not in the myenteric plexus by CCK1 receptor in the adult rat.
【24h】

Endogenous cholecystokinin reduces food intake and increases Fos-like immunoreactivity in the dorsal vagal complex but not in the myenteric plexus by CCK1 receptor in the adult rat.

机译:内源性胆囊收缩素可减少成年大鼠背迷走神经复合物中的食物摄入量,并增加背迷走神经复合物中的Fos样免疫反应,但不会增加肌层神经丛中的Fos样免疫反应。

获取原文
获取原文并翻译 | 示例
           

摘要

We hypothesized that endogenous CCK reduces food intake by activating the dorsal vagal complex (DVC) and the myenteric neurons of the gut. To test this hypothesis, adult rats were given camostat mesilate; a nonnutrient releaser of endogenous CCK, by orogastric gavage, and Fos-like immunoreactivity (Fos-LI) was quantified in the DVC and the myenteric plexus. The results for endogenous CCK were compared with those for exogenous CCK-8. Exogenous CCK-8 reduced food intake and stimulated Fos-LI in the DVC and in myenteric neurons of the duodenum and jejunum. In comparison, endogenous CCK reduced food intake and increased DVC Fos-LI but did not increase Fos-LI in the myenteric plexus. Similar to CCK-8, devazepide, a specific CCK(1) receptor antagonist, and not L365,260, a specific CCK(2) receptor antagonist, attenuated the reduction of food intake by camostat. In addition, Fos-LI in the DVC in response to both exogenous CCK-8 and camostat administration was significantly attenuated by vagotomy, as well as byblocking CCK(1) receptors. These results demonstrate for the first time that reduction of food intake in adult rats by endogenous CCK released by a nonnutrient mechanism requires CCK(1) receptors, the vagus nerve, and activation of the DVC, but not the myenteric plexus.
机译:我们假设内源性CCK通过激活背侧迷走神经复合体(DVC)和肠道的肌层神经元来减少食物摄入。为了验证这一假设,成年大鼠服用了康美司他甲磺酸盐。 DVC和肌间神经丛中通过口腔管饲法检测了内源性CCK的非营养释放剂和类Fos免疫反应性(Fos-LI)。将内源性CCK的结果与外源性CCK-8的结果进行比较。外源CCK-8减少了食物摄入,并刺激了DVC以及十二指肠和空肠的肌层神经元中的Fos-LI。相比之下,内源性CCK减少了食物摄入并增加了DVC Fos-LI,但并未增加肌间神经丛的Fos-LI。与CCK-8类似,devazepide,一种特定的CCK(1)受体拮抗剂,而不是L365,260,一种特定的CCK(2)受体拮抗剂,减缓了静视器对食物摄入的减少。此外,通过迷走神经切开术以及阻断CCK(1)受体,DVC中对外源CCK-8和camostat给药的应答中的Fos-LI显着减弱。这些结果首次证明,通过非营养机制释放的内源性CCK降低成年大鼠的食物摄入量需要CCK(1)受体,迷走神经和DVC的激活,但不需要肌丛。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号